(DBPK) db x-trackers SP500 2x - Overview
Etf: ETF, Leveraged, Inverse, S&P500, USD
| Risk 5d forecast | |
|---|---|
| Volatility | 28.6% |
| Relative Tail Risk | -6.31% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.08 |
| Alpha | -31.88 |
| Character TTM | |
|---|---|
| Beta | -0.408 |
| Beta Downside | -0.337 |
| Drawdowns 3y | |
|---|---|
| Max DD | 68.10% |
| CAGR/Max DD | -0.43 |
Description: DBPK db x-trackers SP500 2x December 22, 2025
The DB X-Trackers S&P 500 2x Inverse Daily UCITS 1C (ticker DBPK, listed on XETRA) is a German-registered exchange-traded fund that seeks to deliver twice the opposite of the daily performance of the S&P 500 Index. It belongs to the “Trading – Leveraged/Inverse Equity” category, meaning it is designed for short-term tactical exposure rather than long-term buy-and-hold investing.
Key quantitative attributes (as of the most recent data) include an expense ratio of roughly 0.30 % p.a., assets under management of about €300 million, and an average daily trading volume exceeding 2 million shares, which together support relatively tight liquidity and modest tracking error for a 2× inverse product. The fund rebalances its exposure daily, so returns over periods longer than one day can diverge significantly from –2 × the S&P 500 performance due to compounding effects, especially in volatile markets.
Performance drivers are primarily the daily moves of the S&P 500, which in turn are influenced by US macro-economic factors such as Federal Reserve policy, inflation trends, and earnings season. Because the ETF is inverse and leveraged, it tends to gain when the index falls sharply (e.g., during risk-off episodes) but can suffer rapid erosion during bullish phases or prolonged sideways markets.
For a deeper quantitative breakdown, you might explore ValueRay’s interactive dashboard to compare DBPK’s risk-adjusted metrics against peer products.
What is the price of DBPK shares?
Over the past week, the price has changed by +1.40%, over one month by -0.06%, over three months by -5.80% and over the past year by -31.50%.
Is DBPK a buy, sell or hold?
What are the forecasts/targets for the DBPK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 0.1 | -25% |
DBPK Fundamental Data Overview February 03, 2026
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 48.3m EUR (48.3m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 48.3m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 48.3m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 25.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 4.41% (E(48.3m)/V(48.3m) * Re(4.41%) + (debt-free company))
Discount Rate = 4.41% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)